408359-52-4

Basic information

• Product Name: Ethanone, 1-(3-cyclopropylphenyl)- (9CI)
• Synonyms: Ethanone, 1-(3-cyclopropylphenyl)- (9CI);1-(3-Cyclopropylphenyl)
• CAS NO: 408359-52-4
• Molecular Formula: C₁₁H₁₂O
• Molecular Weight: 160.21238
• Product Categories: ACETYLGROUP
• Mol File: 408359-52-4.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethanone, 1-(3-cyclopropylphenyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(3-cyclopropylphenyl)- (9CI)(408359-52-4)
• EPA Substance Registry System: Ethanone, 1-(3-cyclopropylphenyl)- (9CI)(408359-52-4)

Safety Data

• Hazardous Substances Data: 408359-52-4(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-(3-cyclopropylphenyl)- (9CI), also known as 3'-cyclopropyl-acetophenone, is a chemical compound belonging to the class of ketones. It is identified by its molecular formula C11H12O and has a molecular weight of 160.21 g/mol. Ethanone, 1-(3-cyclopropylphenyl)- (9CI) is characterized by its aromatic and cyclopropyl groups, making it a unique and potentially valuable molecule for pharmaceutical and industrial applications. It may have potential uses in the development of new drugs, flavors, and fragrances or as an intermediate in organic synthesis. However, further research and testing are needed to determine its full range of potential applications and effects.

Upstream product

• 2142-63-4 1-(3-Bromophenyl)ethanone 
• 411235-57-9 cyclopropylboronic acid 
• 39172-32-2 2-(3-bromophenyl)-2-methyl-[1,3]dioxolane 
• 23719-80-4 cyclopropylmagnesium bromide 

Downstream Products

• 627463-23-4 2-bromo-1-(3-cyclopropylphenyl)ethan-1-one 

Relevant articles and documents

BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF

The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF

The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.

DIAMINOTHIAZOLES

The present invention is directed to novel diaminothiazoles of formula These compounds inhibit cyclin-dependent kinase 4 (Cdk4) and are selective against Cdk2 and Cdk1. These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment 6r control of breast, lung and colon and prostate tumors.